• English
  • Eesti

Uuendati humaanravimi müügiluba kehtivusega 1 aasta (seisuga 02.04.2019)

03.04.2019
Printer-friendly version
Müügiloa hoidjaRavimi nimetusATC koodToimeainedRavimvorm, tugevus, pakendi suurusMüügiloa numberKuuluvused
Adamed Sp. z.o.o.CILOZEKB01AC23tsilostasooltabl 50mg N7; N14; N20; N28; N30; N50; N56; N60; N98; N100840114R
Adamed Sp. z.o.o.CILOZEKB01AC23tsilostasooltabl 100mg N7; N14; N20; N28; N30; N50; N56; N60; N98; N100840014R
AS GrindeksOMEPRAZOLE GRINDEKSA02BC01omeprasoolgastroresistentne kapsel 20mg N7; N14; N28; N30; N56; N60; N500815013R
Glaxo Group Ltd.FORTUMJ01DD02tseftasidiimsüste- või inf pulber 1000mg N1214898R
PharmaSwiss Ceska republika s.r.oSENTOBAC02KX01bosentaantabl 62,5mg N14; N28; N56; N112841614R
PharmaSwiss Ceska republika s.r.oSENTOBAC02KX01bosentaantabl 125mg N14; N28; N56; N112841714R
Sandoz Pharmaceuticals d.d.ROXARDIOC10AA07rosuvastatiintabl 10mg N7; N10; N14; N15; N20; N28; N30; N42; N50; N56; N60; N84; N98; N100689710R
Sandoz Pharmaceuticals d.d.ROXARDIOC10AA07rosuvastatiintabl 20mg N7; N10; N14; N15; N20; N28; N30; N42; N50; N56; N60; N84; N98; N100689610R
Sandoz Pharmaceuticals d.d.CAPECITABINE SANDOZL01BC06kapetsitabiintabl 150mg N28; N30; N50; N56; N60; N80; N84; N90; N100; N110; N112; N120; N180814513R
Sandoz Pharmaceuticals d.d.CAPECITABINE SANDOZL01BC06kapetsitabiintabl 500mg N28; N30; N50; N56; N60; N80; N84; N90; N100; N110; N112; N120; N180814413R